Form D · Pharmaceuticals
SEQUOIA PHARMACEUTICALS INC
Gaithersburg, MD · CIK 0001167157
Offering snapshot reported Jun 9, 2009 · SEC filing
- Reported sold
- $3.8M Offering amount: $5.6M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $513 Reported outside-investor minimum
- First sale
- Jun 2, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 9, 2009 | Initial | $3,800,000 | No comparison | 7 | SEC filing |
| Jan 4, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 1, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-39714
Source: Form D, filed Jun 9, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Erickson | Director, Executive |
| Daniel L. Kisner | Director, Executive |
| Denis Lucquin | Director |
| Muzammil Mansuri | Director |
| Douglas Onsi | Director |
| Linda Peters | Director |
| Steve Skolsky | Director, Executive |
| David Summa | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
401 Professional Drive Suite 200
Gaithersburg, MD, 20879
Gaithersburg, MD, 20879